# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Goldman Sachs analyst Neil Mehta maintains Helmerich & Payne (NYSE:HP) with a Sell and lowers the price target from $38 ...
Benchmark analyst Kurt Hallead reiterates Helmerich & Payne (NYSE:HP) with a Hold.
RBC Capital analyst Keith Mackey maintains Helmerich & Payne (NYSE:HP) with a Sector Perform and raises the price target...
Helmerich & Payne acquires KCA Deutag for $1.9725 billion, expanding its Middle East operations and boosting cash flow.
Benchmark analyst Kurt Hallead reiterates Helmerich & Payne (NYSE:HP) with a Hold.